Effect of cysteine ethylester hydrochloride (Cystanin) on host defense mechanisms (V): Potentiation of nitroblue tetrazolium reduction and chemiluminescence in macrophages or leukocytes of mice or rats.
スポンサーリンク
概要
- 論文の詳細を見る
L-Cysteine ethylester hydrochloride (Cystanin®, ethylcysteine) at doses of 3-30 mg/kg, p.o., potentiated the reduction of nitroblue tetrazolium (NBT) by mouse peritoneal macrophages ex vivo. In in vitro experiments, this drug (30 μM) augmented NBT reduction of mouse peritoneal macrophages induced by opsonized zymosan (OZ). At the same concentration, this drug accelerated the enhancement of the OZ-induced NBT reduction by the addition of concanavalin A, N-formyl-L-methionyl-L-leucyl-L-phenylalanine or phorbol myristate acetate. This enhancing effect of ethylcysteine was completely diminished by the addition of SOD, sodium azide and catalase. In ex vivo experiments, the OZ-induced chemiluminescence of rat peritoneal macrophages and white blood cells was enhanced by the administration of ethylcysteine at doses of 3-10 mg/kg (i.p.) and 3-30 mg/kg (p.o.). In addition, this drug significantly enhanced the lumisphere-induced chemiluminescence of rat peritoneal leukocytes at 30 mg/kg (i.p.), but not the OZ-induced chemiluminescence. In in vitro experiments, this drug (30 μM) did not enhance the OZ-induced chemiluminescence response of rat peritoneal macrophages. These results suggest that ethylcysteine may enhance the intracellular generation of antimicrobial oxidants in macrophages and leukocytes.
- 公益社団法人 日本薬理学会の論文
著者
-
Hisadome Masao
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd.
-
Terasawa Michio
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd
-
FUKUDA Tetsuko
Research Laboratories, Yoshitomi Pharmaceutical Industries, Ltd.
関連論文
- Evaluation of combined antibiotic-omeprazole therapies in Helicobacter pylori-infected Mongolian gerbils
- Suppressive Effects of Y-24180, a Long-Acting Antagonist for Platelet-Activating Factor, on Allergic Pulmonary Eosinophilia in Mice
- IMMUNOPHARMACOLOGICAL PROPERTIES OF NEW ANTIALLERGIC AGENT Y-12,141
- Effect of Y-24180, a Platelet-Activating Factor-Receptor Antagonist, on the Antigen-Induced Airway Microvascular Leakage in Guinea Pigs
- EFFECTS OF 2-{4-(2-IMIDAZO[1, 2-a]PYRIDYL)PHENYL} PROPIONIC ACID (Y-9213) ON IN VIVO RELEASE OF LYSOSOMAL ENZYMES FROM RAT POLYMORPHONUCLEAR LEUKOCYTES DURING PHAGOCYTOSIS OF PARTICLES
- EFFECTS OF 2-{4-(2-IMIDAZO[1, 2-a]PYRIDYL)PHENYL} PROPIONIC ACID (Y-9213) AND ANTI-INFLAMMATORY DRUGS ON ERYTHROCYTES, POLYMORPHONUCLEAR LEUKOCYTES AND LYSOSOMES IN VITRO
- ANTI-ANAPHYLACTIC ACTIVITIES OF A NEW BENZOPYRANOPYRIDINE DERIVATIVE Y-12, 141 IN RATS AND GUINEA PIGS
- TRAXANOX AUGMENTS IMMUNE RESPONSE TO LIPOPOLYSACCHARIDE IN INBRED MICE: ROLE OF MACROPHAGES
- Stimulation of phagocytic activity of leukocytes and macrophages by traxanox sodium in mice and rats.
- Effect of cysteine ethylester hydrochloride (CystaninR) on host defense mechanisms. (IV). Potentiating effects on the function of peritoneal or spleen macrophages.
- An antagonistic activity of etizolam on platelet-activating factor(PAF). In vitro effects on platelet aggregation and PAF receptor binding.
- Effect of etizolam (Depas) on production of superoxide anion by platelet-activating factor and N-formyl-methionyl-leucyl-phenylalanine-stimulated guinea pig polymorphonuclear leukocytes.
- Effect of cysteine ethylester hydrochloride (Cystanin) on host defense mechanisms (V): Potentiation of nitroblue tetrazolium reduction and chemiluminescence in macrophages or leukocytes of mice or rats.